AbbVie secures $3 billion credit facility, total access now $8 billion
AbbVie Inc . (NYSE:ABBV), a Delaware-incorporated pharmaceutical company with a market capitalization of $339 billion and annual revenue exceeding $56 billion, has entered into a $3 billion unsecured ...
Jim Cramer Says AbbVie Inc. (ABBV) Is A ‘Buy’
We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are going to take a ...
FiercePharma10h
TV drug ad spending reached new heights in January, as Novartis' Pluvicto toppled AbbVie's Skyrizi for top spot
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
AbbVie (NYSE:ABBV) Price Target Raised to $190.00 at UBS Group
AbbVie (NYSE:ABBV – Get Free Report) had its price target lifted by equities researchers at UBS Group from $181.00 to $190.00 in a note issued to investors on Monday,Benzinga reports. The brokerage ...
AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
AbbVie (NYSE:ABBV – Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $195.00 to $210.00 in a note issued to investors on Monday,Benzinga reports ...
MM&M1d
See the top Black pharma leaders
As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.
AbbVie's SWOT analysis: stock outlook strong despite humira loss
AbbVie Inc . (NYSE:ABBV), currently trading at $190.14, has demonstrated resilience and strategic foresight as it navigates the loss of exclusivity for its blockbuster drug Humira. The ...
S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements
The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key earnings and labor market data.
bovnews2d
AbbVie Inc (ABBV) Reported a 29.61% Operating Margin Last Year—What’s the Real Story?
AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $183.9 which represents a slight increase of $8.25 or 4.70% from the prior close of $175.65. The stock opened at $187.3 and touched a low ...
Why AbbVie Inc. (ABBV) Is Among the Best Cancer Stocks to Buy According to Hedge Funds
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
AbbVie Stock Soars on Key Drugs’ Sales Forecasts
AbbVie shares rose 5.5% Friday, after the company hiked its sales forecasts for two key drugs. The company reported fourth-quarter revenue and earnings above Wall Street's estimates, and forecast that ...
These Stocks Moved the Most Today: Apple, Intel, Chevron, Exxon, Walgreens, AbbVie, Deckers, Atlassian, Vertex, and More
Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts ...